Is Circulating Fibroblast Growth Factor 23 a Surrogate Marker or Active Mediator for the Construction of Atrial Fibrillation Substrate?

被引：1
|
作者：
Niwano, Shinichi [1 ]
机构：
[1] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Sagamihara, Kanagawa 2520374, Japan
来源：
CIRCULATION JOURNAL | 2015年 / 79卷 / 08期
关键词：
CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; FGF23; KLOTHO; METABOLISM; MORTALITY; PHOSPHATE;
D O I：
10.1253/circj.CJ-15-0506
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1685 / 1686
页数：2
相关论文
共 50 条
  • [41] Features of the expression of fibroblast growth factor in patients with idiopathic atrial fibrillation and verified myocarditis
    Gusakova, A.
    Suslova, T. E.
    Shelemehov, A. E.
    Rogovskaya, Y. V.
    Batalov, R. E.
    EUROPEAN HEART JOURNAL, 2021, 42 : 484 - 484
  • [42] Short-term fasting of mice elevates circulating fibroblast growth factor 23 (FGF23)
    Feger, Martina
    Alber, Jana
    Strotmann, Joerg
    Grund, Andrea
    Leifheit-Nestler, Maren
    Haffner, Dieter
    Foeller, Michael
    ACTA PHYSIOLOGICA, 2023, 239 (04)
  • [43] Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
    Mansinho, Andre
    Ferreira, Arlindo R.
    Casimiro, Sandra
    Alho, Irina
    Vendrell, Ines
    Costa, Ana Lucia
    Sousa, Rita
    Abreu, Catarina
    Pulido, Catarina
    Macedo, Daniela
    Pacheco, Teresa R.
    Correia, Lurdes
    Costa, Luis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03):
  • [44] Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo
    Lopez, Ignacio
    Encarnacion Rodriguez-Ortiz, M.
    Almaden, Yolanda
    Guerrero, Fatima
    Montes de Oca, A.
    Pineda, Carmen
    Shalhoub, Vicky
    Rodriguez, Mariano
    Aguilera-Tejero, Escolastico
    KIDNEY INTERNATIONAL, 2011, 80 (05) : 475 - 482
  • [45] Levels of circulating fibroblast growth factor (FGF) 23 and prognosis of cancer patients with bone metastasis
    Mansinho, A. B.
    Ferreira, A. R.
    Casimiro, S.
    Alho, I.
    Vendrell, I.
    Costa, A. L.
    Sousa, R. T. D.
    Abreu, C. D.
    Pulido, C.
    Macedo, D.
    Pacheco, T.
    Correia, L.
    Costa, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [46] Circulating Fibroblast Growth Factor 23 Is Associated with Angiographic Severity and Extent of Coronary Artery Disease
    Xiao, Yunjun
    Peng, Chaoqiong
    Huang, Wei
    Zhang, Jinzhou
    Xia, Min
    Zhang, Yuan
    Ling, Wenhua
    PLOS ONE, 2013, 8 (08):
  • [47] Regulation of circulating fibroblast growth factor-23 by parathyroid hormone in patients with primary hyperparathyroidism
    Kurajoh, Masafumi
    Imanishi, Yasuo
    Kobayashi, Keisuke
    Ishii, Akira
    Nagata, Tomoki
    Inaba, Masaaki
    Miki, Takami
    Nishizawa, Yoshiki
    ENDOCRINE JOURNAL, 2010, 57 : S489 - S489
  • [48] Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia
    Mace, Maria L.
    Gravesen, Eva
    Nordholm, Anders
    Hofman-Bang, Jacob
    Secher, Thomas
    Olgaard, Klaus
    Lewin, Ewa
    KIDNEY INTERNATIONAL, 2017, 92 (01) : 165 - 178
  • [49] Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism
    Sato, T
    Tominaga, Y
    Ueki, T
    Goto, N
    Matsuoka, S
    Katayama, A
    Haba, T
    Uchida, K
    Nakanishi, S
    Kazama, JJ
    Gejyo, F
    Yamashita, T
    Fukagawa, M
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (03) : 481 - 487
  • [50] Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active
    Shimada, Takashi
    Urakawa, Itaru
    Isakova, Tamara
    Yamazaki, Yuji
    Epstein, Michael
    Wesseling-Perry, Katherine
    Wolf, Myles
    Salusky, Isidro B.
    Jueppner, Harald
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02): : 578 - 585
12345